EXEL

Exelixis, Inc. Common Stock

$26.38 +$0.55 +2.08%



Shares Bought6
Shares Sold6
Total12
Shares Owned0
Last Price$26.38
Total Return-$4.49
Range Today$25.45 - $26.52
52 Week Range$14.22 - $32.50
Open$25.79
Market Cap$7.80B
Volume/Average1.26M/4.34M
P/E Ratio53.84
Dividend/Yield-




Exelixis, Inc. is a biopharmaceutical company. It engages in the developing and commercializing small molecule therapies for the treatment of cancer. The company brands include comertriq and cobimetinib. Its pipeline consists of cabozantinib, cobimetinib and Xl 888. Exelixis was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-01-17 21:18 11-07-17 22:21 $25.60 $26.56 +$0.96 +3.75% funkmasterflexion
08-16-17 15:10 09-26-17 13:19 $26.95 $23.50 -$3.45 -12.80% radiatoren
08-16-17 14:59 09-26-17 13:17 $26.86 $23.50 -$3.36 -12.49%
09-25-17 16:21 09-26-17 13:14 $23.45 $23.50 +$0.05 +0.22% funkmasterflexion
09-25-17 16:10 09-26-17 13:12 $23.61 $23.50 -$0.11 -0.47% funkmasterflexion
08-16-17 14:58 08-30-17 21:47 $26.89 $28.30 +$1.41 +5.24%